In this session, panelists discuss some of the most prominent regulatory and legislative initiatives central to the natural products sector, including a possible FDA definition of the term "natural," recent class action litigation developments and self-regulatory efforts to define the term "natural," and where regulators are going (or should be going) when it comes to substantiating claims for natural products.
Speaker:
Randal M. Shaheen, Partner, Venable LLP
Visit The Big Natural to learn more.